Department of Cancer Research 

Our vision is to impact patients’ life by advancing the fight against cancer. Based on strong scientific track-records, we focus on priority research areas and provide research expertise covering the most common and/or malignant cancer types representing a health burden in Luxembourg. The department also represents a state-of-the-art training ground for next generation cancer researchers and acts as a reference point for cancer research in Luxembourg. 

Mission

The main mission of the DoCR is to advance the treatment options of cancer and reduce the cancer burden within the Luxembourg population and beyond. It does so through research excellence in priority areas covering the basic, translational and clinical research landscape to foster personalised medicine programmes. Its activities focus on cancers which are difficult to treat. Its team, composed of multiple Research Groups, has dedicated expertise in cancer immunology, the tumour microenvironment, tumor metabolism and neuro-oncology. They explore the cellular and molecular mechanisms of tumor progression using a wide range of state-of-the-art technologies, including multimodal omics technologies (genomics, metabolomics…), advanced immunoprofiling analysis, as well as ex vivo and in vivo imaging modalities leveraging patient data and innovative patient-derived models for cancer research.

DIRECTOR OF DEPARTMENT

Johannes
Meiser

VISIT OUR
RESEARCH PORTAL

The LIH Research Portal allows you to search and find information about all active researchers, units, outputs, projects and infrastructures.

Projects & clinical trials

Featured team members

  • Rafael
    Barros
    Laboratory Assistant
  • Elisabetta
    Bartolini
    PhD Student
  • Michaela
    Bauer
    Postdoctoral Fellow
  • Amandine
    Bernard
    Laboratory Technician
  • Coralie
    Borne
    Postdoctoral Fellow
  • Selma
    Boudissa
    Research Engineer
  • Eleonora
    Campus
    PhD Student
  • Maryna
    Chepeleva
    PhD Student

Scientific publications

Related News

CANBIO

CANBIO is a doctoral research and training unit (DTU) addressing the clinical problem of tumour progression and recurrence. PhD candidates within CANBIO are engaged in a collaborative and interdisciplinary endeavour to deliver novel insight into tumour escape mechanisms, disease monitoring and large scale data analysis in highly malignant cancers.

i2TRON

TTM is taking a leading role in the coordination of i2TRON, a doctoral training unit (DTU) with a strong focus on developing the new generation of translational scientists, who can turn observations in the laboratory, clinical setting or community into interventions that improve the health of individuals via innovative diagnostics or treatments. 

Visit the dedicated webpage for more information:  

Job vacancies